Advocacy intelligence hub — real-time data for patient organizations
AstraZeneca — PHASE1
Anwaar Saeed — PHASE1
Saglik Bilimleri Universitesi — NA
Acrivon Therapeutics — PHASE1
Zhuhai Yufan Biotechnologies Co., Ltd — PHASE1, PHASE2
Zhuhai Yufan Biotechnologies Co., Ltd — PHASE1
Restorbio Inc. — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Hereditary sensory and autonomic neuropathy news →
Benedetto Falsini, MD
universita Cattolica del S. Cuore/Fondazione policlinico A. Gemelli, IRCCS
📍 Rome
David Bajor, MD, MD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
📍 CLEVELAND, OH
Norman Wolmark, MD
Cancer Center at Saint Joseph's
📍 Phoenix, Arizona
View all Hereditary sensory and autonomic neuropathy specialists →